Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for N71542109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| ELI LILLY & Co 13G/A | 15.6% |
7/24/2026
Event 6/26/2026
|
|
|
Van Herk Investments B.V.
13D/A
|
10.9% |
7/29/2026
Event 7/27/2026
|
|
| Van Herk Investments B.V. | 10.9% | ||
| Van Herk Investments THI B.V. | 10.9% | ||
| Van Herk Private Equity Investments B.V. | 10.9% | ||
| Stichting Administratiekantoor Penulata | 10.9% | ||
| Van Herk Management Services B.V. | 10.9% | ||
| Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V. | 10.9% | ||
| A. van Herk Holding B.V. | 10.9% | ||
| Stichting Administratiekantoor Abchrys | 10.9% | ||
| Adrianus van Herk | 10.9% | ||
|
Aberdeen Group plc
13G
|
6.3% |
7/29/2026
Event 6/30/2026
|
|
| Aberdeen Group plc | 6.3% | ||
| abrdn Inc. | 6.3% | ||
|
Adage Capital Management, L.P.
13G/A
|
6.3% |
8/12/2025
Event 6/30/2025
|
|
| Adage Capital Management, L.P. | 6.3% | ||
| Robert Atchinson | 6.3% | ||
| Phillip Gross | 6.3% | ||
|
Privium Fund Management B.V.
13G/A
|
5.2% |
7/15/2026
Event 7/15/2026
|
|
| Stichting Aescap Life Sciences | 3.0% | ||
| Privium Fund Management B.V. | 3.9% | ||
| Stichting Aescap Genetics | 0.9% | ||
| Inspirational Visions B.V. | <0.1% | ||
| Patrick Johan Hendrik Krol | 5.2% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 8 | 191 k | $317 k |
| 2026 Q2 | 70 | 60.7 M | $113 M |
| 2026 Q1 | 70 | 35.1 M | $56.8 M |
| 2025 Q4 | 67 | 37.2 M | $75.1 M |
| 2025 Q3 | 65 | 37.5 M | $80.0 M |
| 2025 Q2 | 65 | 40.6 M | $82.6 M |
| 2025 Q1 | 69 | 41.3 M | $54.9 M |
| 2024 Q4 | 83 | 44.4 M | $117 M |
| 2024 Q3 | 53 | 17.4 M | $31.7 M |
| 2024 Q2 | 54 | 17.4 M | $28.8 M |
| 2024 Q1 | 56 | 17.5 M | $40.1 M |
| 2023 Q4 | 52 | 18.5 M | $37.2 M |
| 2023 Q3 | 47 | 18.7 M | $24.1 M |
| 2023 Q2 | 55 | 21.1 M | $34.2 M |
| 2023 Q1 | 60 | 22.3 M | $47.5 M |
| 2022 Q4 | 53 | 16.7 M | $60.0 M |
| 2022 Q3 | 51 | 21.3 M | $15.9 M |
| 2022 Q2 | 57 | 22.1 M | $17.2 M |
| 2022 Q1 | 71 | 31.9 M | $28.9 M |
| 2021 Q4 | 84 | 45.5 M | $365 M |
| 2021 Q3 | 74 | 39.8 M | $333 M |
| 2021 Q2 | 67 | 38.5 M | $259 M |
| 2021 Q1 | 73 | 43.3 M | $286 M |
| 2020 Q4 | 50 | 26.4 M | $111 M |
| 2020 Q3 | 45 | 28.0 M | $134 M |
| 2020 Q2 | 47 | 29.1 M | $177 M |
| 2020 Q1 | 49 | 29.3 M | $161 M |
| 2019 Q4 | 55 | 30.2 M | $299 M |
| 2019 Q3 | 51 | 21.7 M | $125 M |
| 2019 Q2 | 56 | 23.6 M | $215 M |
| 2019 Q1 | 56 | 24.0 M | $333 M |
| 2018 Q4 | 60 | 23.1 M | $365 M |
| 2018 Q3 | 37 | 19.5 M | $378 M |
| 2018 Q2 | 25 | 11.1 M | $80.8 M |
| 2018 Q1 | 25 | 10.7 M | $32.9 M |
| 2017 Q4 | 27 | 11.5 M | $37.1 M |
| 2017 Q3 | 23 | 10.1 M | $48.9 M |
| 2017 Q2 | 18 | 9.00 M | $46.8 M |
| 2017 Q1 | 21 | 9.06 M | $45.3 M |
| 2016 Q4 | 24 | 8.94 M | $43.8 M |
| 2016 Q3 | 25 | 8.69 M | $58.0 M |
| 2016 Q2 | 26 | 9.15 M | $44.3 M |
| 2016 Q1 | 29 | 9.63 M | $46.9 M |
| 2015 Q4 | 32 | 11.2 M | $97.1 M |
| 2015 Q3 | 38 | 11.9 M | $173 M |
| 2015 Q2 | 37 | 10.8 M | $181 M |
| 2015 Q1 | 38 | 11.0 M | $241 M |
| 2014 Q4 | 36 | 8.23 M | $177 M |
| 2014 Q3 | 30 | 7.63 M | $130 M |